News
-
-
-
PRESS RELEASE
Abivax Announces Acceptance of 22 Abstracts Evaluating Obefazimod in Inflammatory Bowel Disease at ECCO 2026, Featuring an Oral Presentation on Preclinical Anti-Fibrotic Findings
Abivax announces acceptance of 22 abstracts evaluating Obefazimod in Inflammatory Bowel Disease at ECCO 2026, featuring oral presentation on preclinical anti-fibrotic findings -
-
-
-
-
-
PRESS RELEASE
EQS-Adhoc: Rheinmetall AG: Executive Board decides to sell activities of the civil division Power Systems – Target is sale in the first quarter of 2026; update of outlook for continuing operation
Rheinmetall AG Executive Board decides to sell civil division activities, aiming for sale in Q1 2026. Outlook updated for continuing operations in 2025 financial year -